13F Filings History of Integral Health Asset Management, LLC

Latest 13F report
Q3 2025 - Nov 14, 2025
Value $
$1.37B
Signature - Title
John Del Virginia - Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Integral Health Asset Management, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Integral Health Asset Management, LLC reported 72 stock holdings with total value $1.37B as of Q3 2025. Top holdings included INSM, CYTK, THC, MLYS, and VERA.

Notify me when Integral Health Asset Management, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2025 72 $1.37B +$312M -$305M +$6.5M INSM, CYTK, THC, MLYS, VERA 13F-HR 11/14/2025, 08:39 AM
Q2 2025 70 $1.07B +$301M -$195M +$106M INSM, BSX, THC, EHC, MLYS 13F-HR 8/14/2025, 08:17 AM
Q1 2025 76 $903M +$287M -$476M -$189M INSM, BSX, CYTK, THC, MLYS 13F-HR 5/15/2025, 07:01 AM
Q4 2024 81 $1.13B +$516M -$194M +$321M INSM, THC, BSX, VERA, CYTK 13F-HR 2/14/2025, 09:41 AM
Q3 2024 63 $849M +$221M -$431M -$210M INSM, THC, BSX, CYTK, LBPH 13F-HR 11/14/2024, 11:30 AM
Q2 2024 69 $1B +$319M -$344M -$25.5M INSM, THC, CYTK, BSX, ELV 13F-HR 8/14/2024, 08:04 AM
Q1 2024 75 $1.01B +$437M -$223M +$214M THC, BSX, VKTX, INSM, CYTK 13F-HR 5/15/2024, 11:14 AM
Q4 2023 67 $693M +$346M -$435M -$88.6M WBA, THC, ABBV, NVS, REGN 13F-HR 2/14/2024, 10:28 AM
Q3 2023 96 $720M +$333M -$367M -$34M THC, ARGX, BSX, MLTX, CYTK 13F-HR 11/14/2023, 08:57 AM
Q2 2023 73 $808M +$496M -$41.2M +$455M CI, ZBH, INSP, MCK, BSX 13F-HR 8/11/2023, 10:55 AM
Q1 2023 71 $496M +$240M -$54.5M +$185M ELV, CYTK, INSP, COO, SYK 13F-HR 5/9/2023, 12:47 PM
Q4 2022 61 $476M +$242M -$72.6M +$169M CYTK, MRNA, BMRN, MRK, DGX 13F-HR 2/13/2023, 09:53 AM
Q3 2022 64 $511M +$219M -$84.6M +$134M GH, ELV, CNC, CYTK, BAX 13F-HR 11/14/2022, 09:55 AM
Q2 2022 65 $486M +$240M -$13M +$227M ELV, CNC, LLY, CYTK, SNY 13F-HR 8/3/2022, 02:13 PM
Q1 2022 71 $384M +$158M -$28.3M +$130M ELV, CYTK, PFE, GMED, RVTY 13F-HR 5/12/2022, 04:26 PM
Q4 2021 71 $361M +$142M -$41.1M +$101M CNC, SAGE, CYTK, RVTY, MCK 13F-HR 2/2/2022, 09:17 AM
Q3 2021 70 $348M +$140M -$150M -$9.88M ARNA, ACHC, SAGE, CVS, CYTK 13F-HR 11/12/2021, 10:26 AM
Q2 2021 71 $363M +$154M -$161M -$7.09M ELV, ACHC, ARNA, CYTK, SAGE Restatement 8/30/2021, 12:05 PM
Q1 2021 69 $350M +$148M -$130M +$18M ACHC, CYTK, ARNA, NVST, NTLA 13F-HR 5/10/2021, 09:54 AM
Q4 2020 57 $336M +$126M -$48.1M +$78.4M SAGE, ACHC, ARNA, NVRO, LHCG 13F-HR 2/16/2021, 03:13 PM
Q3 2020 72 $327M +$130M -$62.9M +$66.9M LHCG, SAGE, RVTY, ABT, ARNA 13F-HR 11/16/2020, 10:43 AM
Q2 2020 60 $334M +$166M -$27.9M +$138M LHCG, DGX, BMY, ARNA, BMRN 13F-HR 8/14/2020, 09:30 AM
Q1 2020 50 $225M +$147M -$15.7M +$131M MDT, CNC, MRK, BMY, DGX 13F-HR 5/15/2020, 01:24 PM
Q4 2019 50 $257M A, DXCM, BMY, MDT, AMED 13F-HR 2/13/2020, 10:21 AM